文献速递神经核医学肿瘤 PET/CT

海绵窦内神经鞘瘤的18F-FDG、68Ga-DOTATOC与18F-胆碱PET表现

Intracavernous Schwannoma Characterized With 18F-FDG, 68Ga-DOTATOC, and 18F-Choline PET.
PubMed 文献 · Clin Nucl Med · 2022-01-01

本文报道一名75岁有前列腺癌病史的男性,左侧海绵窦内病变在MRI随访中缓慢增大,先后行18F-FDG、68Ga-DOTATOC及18F-胆碱PET。病变FDG无明显摄取,DOTATOC无摄取,胆碱摄取高,未见颅外病灶,活检证实为无恶性标准的神经鞘瘤。

要点

  • 海绵窦内神经鞘瘤18F-FDG可无明显摄取。
  • 68Ga-DOTATOC在该神经鞘瘤中无摄取。
  • 18F-胆碱PET显示该病变高摄取,活检证实为神经鞘瘤。

核心结论

  • 海绵窦内神经鞘瘤可表现为18F-FDG无明显摄取、68Ga-DOTATOC无摄取而18F-胆碱高摄取,活检证实无恶性标准。

研究设计与样本

  • 单例病例报告:75岁有前列腺癌病史男性,左侧海绵窦内病变因急性复视行MRI发现,随访中缓慢增大,先后行三种不同示踪剂PET。

主要发现

  • 18F-FDG PET示病变无明显摄取,且未发现颅外病灶。
  • 68Ga-DOTATOC PET示病变无摄取增加。
  • 18F-胆碱PET示病变高摄取,且未发现颅外病灶。
  • 活检证实为神经鞘瘤,无恶性标准。

临床怎么用

  • 对海绵窦内缓慢生长、性质未明的病变,可结合多种PET示踪剂表现辅助鉴别,最终仍需活检证实。

局限性

  • 仅为单例病例报告,结果不能外推为普遍诊断标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We report the case of a 75-year-old man with history of prostate cancer whose left intracavernous lesion was successfully characterized by 3 PETs performed successively with different tracers. This poorly characterized tumor was initially discovered on an MRI conducted to investigate an acute diplopia and slowly growing during follow-up. On 18F-FDG PET, the lesion showed no significant uptake, and no extracranial lesion was found nor did it have increased 68Ga-DOTATOC uptake. Finally, this tumor displayed a high 18F-choline uptake, and no extracranial lesion was revealed with this tracer. The diagnosis of schwannoma without malignancy criterion was proven by biopsy.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Farce J, Lecouillard I, Carsin Nicol B, et al. Intracavernous Schwannoma Characterized With 18F-FDG, 68Ga-DOTATOC, and 18F-Choline PET. Clin Nucl Med. 2022. PMID: 34661554. doi:10.1097/RLU.0000000000003929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。